Description
BREAST CANCEL TEST IGF::OT::IGF
First action · last action
2013-09-30 · 2013-11-05
Transactions
2
First transaction's obligation
$5,000
Base + all options value (sum of deltas)
$0
Extent competed
NOT COMPETED
Other than full & open authority
ONLY ONE SOURCE - OTHER
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
541380 · TESTING LABORATORIES
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-09-30+$5,000= $5,000
- Mod P000012013-11-05-$5,000= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-09-30 | +$5,000 | $5,000 | BREAST CANCEL TEST IGF::OT::IGF |
| Mod P00001· CHANGE ORDER | 2013-11-05 | −$5,000 | $0 | BREAST CANCEL TEST IGF::OT::IGF |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI RHN3L7SBF7J6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0377 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $55,912 | FY2026 |
| 36C26225N0452 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $114,305 | FY2025 |
| 36C26224N0385 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $114,305 | FY2024 |
| 36C26223P1608 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $10,362 | FY2023 |
| 36C26223N0393 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · MEDICAL- LABORATORY TESTING | $194,070 | FY2023 |
| 36C26223A0031 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2023 |
Other recipients under Q301 from 460-WILMINGTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24415F3433 | BIOMERIEUX INC | 460-WILMINGTON | $13,000 | FY2015 |
| VA24414P0570 | VOLCANO CORPORATION | 460-WILMINGTON | $21,700 | FY2014 |
| VA24414P0331 | BARD PERIPHERAL VASCULAR, INC. | 460-WILMINGTON | $3,570 | FY2014 |
| VA24414J4265 | LABORATORY CORPORATION OF AMERICA | 460-WILMINGTON | $369,467 | FY2013 |
| VA24413P3077 | BROMEDICON, INC | 460-WILMINGTON | $6,000 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24413P4573_3600_-NONE-_-NONE- · retrieved 2026-09-26.